Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Compound Chinese herbal medicine improves immune function and alters intestinal microbiome composition of Hoplobatrachus rugulosus

PROVIDER: PRJNA1254130 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR33254076_1.fastq.gz	Fastqsanger.gz
	SRR33254076_2.fastq.gz	Fastqsanger.gz
	SRR33254077_1.fastq.gz	Fastqsanger.gz
	SRR33254077_2.fastq.gz	Fastqsanger.gz
	SRR33254078_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 30

Similar Datasets

Hoplobatrachus rugulosus

Project description:Hoplobatrachus rugulosus overview

| PRJNA182799 | ENA

Project description:Skin microbiota of Hoplobatrachus rugulosus

| PRJNA766330 | ENA

Project description:Transcriptome of gonads in Hoplobatrachus rugulosus

| PRJNA659277 | ENA

Project description:Function and mechanism of traditional chinese medicine herbal formula huoxueyin

| PRJNA1000256 | ENA

Exploration of SQC formula effect on Type 2 diabetes mellitus by whole transcriptome profile in rats

Project description:Type 2 diabetes mellitus (T2DM) is a chronic metabolic disease that has turned up as pandemic dimensions all over the world. In China, some traditional Chinese herbal formulas have enjoyed a high reputation in T2DM treatment for centuries. And ShenQi compound (SQC), a formula has been performed on T2DM clinical therapeutics in China for many years, deserve to study in depth. Gene microarray experiments were performed to explore the molecular mechanism of SQC treatment. In addition, a western medicine, metformin was employed as a comparison.

2021-01-22 | GSE165225 | GEO

Kuiyangling inhibits inflammation by reducing intestinal NETs in mice with ulcerative colitis

Project description:To explore the molecular mechanism of the the Traditional Chinese Medicine compound Kuiyangling on the mouse ulcer model.

2023-02-21 | GSE225420 | GEO

Ganoderma sinense

Project description:A basidiomycete fungus used in Chinese herbal medicine

| PRJNA43103 | ENA

A network pharmacology study of Chinese Medicine QSYQ to reveal its underlying multi-compound, multi-target, multi-pathway mode of action

Project description:Chinese medicine is a complex system guided by traditional Chinese medicine (TCM) theories, which has proven to be especially effective in treating chronic and complex diseases. However, the underlying modes of action (MOA) are not always systematically investigated. Herein, a systematic study was designed to elucidate the multi-compound, multi-target and multi-pathway MOA of a Chinese medicine ,QSYQ, on myocardial infarction. Male Sprague Dawley rat model of myocardial infarction were administered QSYQ intragastrically for 7 days while the control group was not treated. The differentially expressed genes (DEGs) were identified from myocardial infarction rat model treated with QSYQ, followed by constructing a cardiovascular disease (CVD)-related multilevel compound-target-pathway network connecting main compounds to those DEGs supported by literature evidences and the pathways that are functionally enriched.

2014-01-17 | GSE54134 | GEO

Finding two synergized compounds from Chinese herbal medicine in rheumatoid arthritis therapy

Project description:Purpose: To search candidate synergized compounds from Chinese herbal medicine used in RA therapy Methods: Candidate synergized compounds were searched based on multi-information integrative approaches. In vivo experiment in collagen induced arthritis rat was then carried out to evaluate the efficacy and synergism of compounds combination treatment. RNA sequencing and IPA were used to investigate the synergized mechanism of combination treatment. Results: We found a pair of compound combination which could alleviate the symptom of CIA rats. RNA sequencing and IPA analysis revealed that the synergistic mechanism of combination treatment was related to several canonical signaling pathways and key targets LTA, CD83 and SREBF1. Conclusion: A pair of compound combination has been found. RNA sequencing and IPA analysis revealed that the synergistic mechanism of combination treatment was related to several canonical signaling pathways and key targets.

2021-09-20 | GSE148598 | GEO

Clinical study of Jiedu Sangen granules Inhibiting postoperative recurrence and metastasis of stage II~III colorectal cancer based on ‘combination of disease and syndrome’

Project description:Interventions: Integrated traditional Chinese and Western medicine group:Standard western medicine treatment and Taking herbal granules ;Western medicine group:Standard western medicine treatment Primary outcome(s): Disease-free survival Study Design: Cohort study

| 2668429 | ecrin-mdr-crc

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data